-
Industry Update
Fellowluminaries, a popular Cook Medical educational program for fellows, continues its tradition with an upcoming event to coincide with the APDVS and UCLA Symposia at the Renaissance Hotel in Hollywood, California. This year's speaker, Dr. Benjamin Star...
-
Management Message
James Macnaughtan, Asia-Pacific Leader, Aortic InterventionTwenty-five of China's leading practitioners in EVAR and TEVAR recently gathered at the China Endovascular Summit held in the city of Harbin in the Heilongjiang province, in northern China. The ev...
-
Clinical Corner
As the baby boomer generation ages, an increase in the diagnosis of critical limb ischemia (CLI) is evident. CLI indicates that a patient is in the late stages of peripheral arterial disease (PAD). CLI affects the extremities, most commonly the arteries b...
-
Management Message
Chris Pedersen, National Sales Manager, The AmericasLeadership, team play and territory growth (through service, clinical knowledge and effort) are the characteristics I personally use when evaluating my sales representatives. Last month, at our North/Sou...
-
Product Spotlight
Zenith TX2 with Pro-Form Is Now Approved for Use in the United StatesA major issue in the endovascular repair of thoracic abdominal aneurysms is the formation of a "bird's beak" gap, which in this context can be created when a stent graft does not properl...
-
Clinical Corner
Dr. Jim Gardner- Medical Science Officer, Director of Reimbursement, Cook Medical and Devin Zysling, PhD, Regulatory Science Associate, Cook MedicalEndovascular stent graft placement is becoming widespread in the treatment of abdominal aortic aneurysm dis...
-
Management Message
Eric Slater- Zenith Planning and Sizing SpecialistIt has been said by many individuals that a good percentage of the work involved in any TEVAR case is planning the case. With this in mind, I would like to discuss some of the important points involved in ...
-
Product Spotlight
In a development aimed at enhancing safety for all patients undergoing endovascular repair of abdominal aortic aneurysms and open the clinical benefits of that minimally invasive procedure to millions of patients worldwide whose vascular anatomies are uns...
-
Product Spotlight
"The best thoracic device on the market just got better!" That's the way Cook Medical's Ray Leonard sums up the improvements made to the TX2 delivery system. "The Z-Trak Plus gives physicians unprecedented levels of control throughout the procedure."...
-
Clinical Corner
Dr. Steven Cheng, Chief of the Division of Vascular Surgery University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong, ChinaShort and wide common iliac arteries are common in the Asian population (Figure 1). A previous study examining 65 Chin...
-
Management Message
AAA patients often have no symptoms. Yet, after an EVAR, they are often discharged with symptoms that can severely disrupt their recovery and quality of life. These symptoms are caused by the internal iliac artery being intentionally occluded due to aneur...
-
Product Spotlight
Patients undergoing endovascular repair of thoracic aneurysms can now receive the clinical benefits of Cook Medical's new Zenith TX2 TAA Endovascular Graft with Pro-Form for more controlled treatment of thoracic aortic aneurysms (TAAs). Cook's new TX2 wit...
-
Industry Update
Professor Ralf Kolvenbach, of the Augusta Hospital and Catholic Clinics in Dsseldorf, Professor at the University of Dsseldorf, is the first vascular surgeon to have repaired a TAA with the TX2 with Pro-Form. "Using the TX2 Pro-Form, I was able to seal th...
-
Management Message
Sometimes the simplest solutions to complex problems are the best solutions. This was confirmed recently when engineers at Cook Medical's Aortic Intervention division were asked to address the challenge of poor proximal conformity -- the Achilles' heel of...
-
Clinical Corner
Dr. Matt Thompson, Professor of Vascular SurgerySt. George's Vascular InstituteThoracic aortic endografts are in a relatively immature state of evolution when compared to their abdominal counterparts. One of the developmental issues for consideration in t...
-
Industry Update
We are excited to announce a new feature section debuting in this edition of The Landing Zone -- the SVS Podcast of the Month. A link beneath the "Upcoming EVAR Events" section of The Landing Zone (on the right-hand side of the homepage) will take you dir...
-
Clinical Corner
Melissa Kirkwood, MDIncoming vascular surgery fellows who attended the Cook Medical Fellowluminaries at this year's Society for Clinical Vascular Surgery conference enjoyed a stimulating lecture series, gained practical advice about life after fellowship,...
-
Clinical Corner
TX2 in the News For every market in which the Zenith TX2 TAA Endovascular Graft has been approved, the physician response has been excellent. Proof of this comes from consistent monthly sales growth, strong physician interest in training, and a global inc...
-
Management Message
During an interview for a Zenith sales training session, Dr. Bill Ranger of Munson Medical Center in Traverse City, Michigan, summed up what in his mind separates the good sales rep from the great sales rep. He said it was three A's -- affability, availab...
-
Management Message
The Zenith AAA Endovascular Graft first became commercially available in Australia in the late 1990s. Its introduction in Europe soon followed (1999), and subsequent FDA approval and launch in the U.S. came in 2003.The clinical study, along with extensive...
